Type 1 Diabetes Mellitus
Conditions
Keywords
Type 1 diabetes mellitus, Socio-Ecological Model, Physical Activity
Brief summary
The goal of this observational study is to examine the multilevel factors influencing physical activity participation in adolescents with Type 1 diabetes (T1D) within the framework of the Socio-Ecological Model (SEM). Physical activity is a multidimensional behavior shaped by individual, interpersonal, institutional, community, and policy-level influences, and it plays a critical role in diabetes management, metabolic health, and overall well-being in youth with T1D. The main questions it aims to answer are: Do factors at the individual, interpersonal, institutional, community, and policy levels of the Socio-Ecological Model significantly influence physical activity participation, social participation, and diabetes management in adolescents with Type 1 diabetes? Which modifiable barriers and facilitators at these multiple levels are associated with higher or lower levels of physical activity? Participants diagnosed with Type 1 diabetes will complete questionnaires assessing their daily living activities, exercise habits, social participation, psychosocial characteristics, and perceived social and environmental support. Objective measurements related to circadian rhythm patterns and glycemic control will also be collected. The study will analyze how multilevel socio-ecological factors are associated with physical activity behavior, social engagement, and diabetes management outcomes. The findings are expected to provide a comprehensive biopsychosocial understanding of physical activity behaviors in adolescents with Type 1 diabetes and to inform the development of supportive, school- and community-based intervention strategies aimed at improving quality of life, self-efficacy, psychological resilience, and sustainable participation in physical activity.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Diagnosed with Type 1 diabetes at least 1 year prior to enrollment, * Aged between 9 and 18 years, * Currently attending school in Istanbul, * Willing to participate in the study (with voluntary consent), * HbA1c value ≥ 8% within the past year, * Reported glucose metabolism biomarkers, * Sufficient cognitive ability to understand and complete the questionnaires, * Under regular medical follow-up and using at least one glucose monitoring device.
Exclusion criteria
* Lack of parental consent, * Presence of additional neurological, motor, or cognitive disorders, * Inadequate mental status or diagnosis of moderate to severe intellectual disability, * Presence of systemic comorbid diseases, * Failure to report HbA1c data.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Physical activity level | 7 days | Physical activity level will be objectively assessed using a wearable accelerometer worn on the dominant arm for seven consecutive days. PAL will be calculated as the ratio of total energy expenditure to basal metabolic rate and expressed as a unitless value. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Fasting Blood Glucose | Assessed at baseline | Fasting blood glucose levels will be measured over seven consecutive days using glucose meters or continuous glucose monitoring (CGM) systems and expressed in mg/dL. |
| Social Participation | At baseline | Social Participation: Social participation will be measured using the CASP, a scale assessing participation at home, school, and in the community. Scores will be transformed to a 0-100 scale, with higher scores indicating greater participation. |
| Diabetes Self-Efficacy | At baseline | Self-efficacy will be assessed using the self-efficacy subscale of the Multidimensional Diabetes Questionnaire. Scores range from 0 to 100, with higher scores indicating greater perceived self-efficacy. |
| Chronotype | At baseline | Chronotype will be assessed using the Childhood Chronotype Questionnaire (CCTQ), a parent-reported instrument adapted from the Munich Chronotype Questionnaire and the Morningness-Eveningness Scale for Children. |
| Daily Step Count | 7 days | Daily step count will be measured using a wearable accelerometer worn on the dominant arm for seven consecutive days and expressed as steps per day. |
| Glycated Hemoglobin (HbA1c) | At baseline | Glycemic control will be assessed using glycated hemoglobin (HbA1c) levels obtained from venous blood samples and expressed as percentage (%). |
| Sedentary Time | 7 days | Time spent in sedentary behavior will be assessed using accelerometer data and expressed in minutes per day. |
Countries
Turkey (Türkiye)